158 related articles for article (PubMed ID: 9394364)
1. Clinical status and optimal use of topotecan.
Takimoto CH; Arbuck SG
Oncology (Williston Park); 1997 Nov; 11(11):1635-46; discussion 1649-51, 1655-7. PubMed ID: 9394364
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
[TBL] [Abstract][Full Text] [Related]
3. New options for the treatment of advanced ovarian cancer.
Dunton CJ
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-2-S5-11. PubMed ID: 9122739
[TBL] [Abstract][Full Text] [Related]
4. Topotecan: a new topoisomerase I inhibiting antineoplastic agent.
Cersosimo RJ
Ann Pharmacother; 1998 Dec; 32(12):1334-43. PubMed ID: 9876816
[TBL] [Abstract][Full Text] [Related]
5. Topotecan - A novel topoisomerase I inhibitor: pharmacology and clinical experience.
Kollmannsberger C; Mross K; Jakob A; Kanz L; Bokemeyer C
Oncology; 1999; 56(1):1-12. PubMed ID: 9885371
[TBL] [Abstract][Full Text] [Related]
6. Topotecan in the first-line treatment of small cell lung cancer.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():33-42. PubMed ID: 15616148
[TBL] [Abstract][Full Text] [Related]
7. The development of camptothecin analogs in childhood cancers.
Bomgaars L; Berg SL; Blaney SM
Oncologist; 2001; 6(6):506-16. PubMed ID: 11743213
[TBL] [Abstract][Full Text] [Related]
8. Topotecan in combination chemotherapy.
Rowinsky EK; Kaufmann SH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-11-S20-26. PubMed ID: 9425957
[TBL] [Abstract][Full Text] [Related]
9. Topotecan in small cell lung cancer.
Schiller JH
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-27-S20-33. PubMed ID: 9425958
[TBL] [Abstract][Full Text] [Related]
10. Topotecan in the treatment of non-small cell lung cancer.
Perez-Soler R
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-34-S20-41. PubMed ID: 9425959
[TBL] [Abstract][Full Text] [Related]
11. Topotecan in the treatment of gynecologic cancer.
Coleman RL; Miller DS
Semin Oncol; 1997 Dec; 24(6 Suppl 20):S20-55-S20-63. PubMed ID: 9425962
[TBL] [Abstract][Full Text] [Related]
12. Topotecan and the treatment of recurrent ovarian cancer: is there a role for granulocyte colony-stimulating factor?
Saltz L; Janik JE
Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-26-S5-30. PubMed ID: 9122740
[TBL] [Abstract][Full Text] [Related]
13. Update on the role of topotecan in the treatment of non-small cell lung cancer.
Stewart DJ
Oncologist; 2004; 9 Suppl 6():43-52. PubMed ID: 15616149
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
Miller AA; Al Omari A; Murry DJ; Case D
Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
[TBL] [Abstract][Full Text] [Related]
15. Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer.
Andreopoulou E; Chen T; Liebes L; Curtin J; Blank S; Wallach R; Hochster H; Muggia F
Cancer Chemother Pharmacol; 2011 Aug; 68(2):457-63. PubMed ID: 21069334
[TBL] [Abstract][Full Text] [Related]
16. Review role of topotecan in gynaecological cancers: current indications and perspectives.
Lorusso D; Pietragalla A; Mainenti S; Masciullo V; Di Vagno G; Scambia G
Crit Rev Oncol Hematol; 2010 Jun; 74(3):163-74. PubMed ID: 19766512
[TBL] [Abstract][Full Text] [Related]
17. Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy.
Jotte R; Conkling P; Reynolds C; Galsky MD; Klein L; Fitzgibbons JF; McNally R; Renschler MF; Oliver JW
J Clin Oncol; 2011 Jan; 29(3):287-93. PubMed ID: 21135284
[TBL] [Abstract][Full Text] [Related]
18. Topotecan--a new treatment option in the therapy of brain metastases of lung cancer.
Schütte W; Manegold C; von Pawel JV; Lan J; Schäfer B; Kaubitzsch S; Staab HJ
Front Radiat Ther Oncol; 1999; 33():354-63. PubMed ID: 10549507
[No Abstract] [Full Text] [Related]
19. Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: a Minnie Pearl Cancer Research Network randomized, prospective phase II trial.
Greco FA; Thompson DS; Morrissey LH; Erland JB; Burris HA; Spigel DR; Joseph G; Corso SW; Spremulli E; Hainsworth JD
Oncologist; 2005 Oct; 10(9):728-33. PubMed ID: 16249353
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetic analysis of topotecan in pediatric cancer patients.
Schaiquevich P; Panetta JC; Iacono LC; Freeman BB; Santana VM; Gajjar A; Stewart CF
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6703-11. PubMed ID: 18006771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
